Sickle Cell Disease; Roadside to Resus

Sickle cell disease, a hereditary hemoglobin disorder, requires urgent, structured emergency care to prevent avoidable mortality and morbidity. The condition stems from a single amino acid mutation in the beta-globin chain, causing red blood cells to sickle under stress, leading to vaso-occlusive crises, tissue infarction, and chronic hemolytic anemia. Effective management centers on the "ACT NOW" framework: prioritizing rapid analgesia, compassion, clinical triggers, hematology consultation, oxygen therapy, and patient warming. Because patients are often experts in their own condition, individualized care plans are vital, particularly regarding opioid administration, which should favor subcutaneous routes over intravenous access to preserve veins. Clinicians must maintain a broad differential, as sickle cell patients are highly susceptible to sepsis, acute chest syndrome, and stroke, requiring early escalation and specialized, age-appropriate intervention to improve long-term outcomes and patient safety.